Adhish Patil, CFO, Aarti Drugs said the slowdown in sales for the third quarter was mainly due to decline in exports and some inventory losses.
Harshit Savla, MD of Aarti Drugs, in an interview with CNBC-TV18’s Gautam Broker and Latha Venkatesh, spoke about the recent happenings in his company and the road ahead.